Published

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropharmacology
Date: 2018-11-01
Source: PubMed
DOI: 10.1016/j.neuropharm.2017.12.041
PubMed: 29288686

Authors

Roseman L Demetriou L Wall MB Nutt DJ Carhart-Harris RL

Watch author

Derived topics and classifications

psilocybin Depression Brain Imaging Emotional Processing Randomized Controlled Trial Treatment-Resistant Depression Other

Citation graph

0 referenced DOIs found in stored source metadata. 10 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression2026-06-01 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01 Human brain changes after first psilocybin use2026-05-05 Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration2026-04-10 Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19 Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review2026-03-09 Acute psilocin increased cortical activity in rat2026-02-04 In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08 Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.2018-11-01

Related papers

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10